The National Institute for Health and Care Research (NIHR) has awarded an NIHR HealthTech Research Centre (HRC) Network £5m ...
The collective landscape of academia-industry clinical trials is undergoing a period of transformation in response to last year’s O’Shaughnessy Review. Birmingham – a prominent hub for clinical trials ...
JHU083 reduced tumour growth and triggered tumour cell death in mice Researchers from the Johns Hopkins Kimmel Cancer Center and Johns Hopkins Drug Discovery have revealed that a novel therapy can ...
A new King’s Doctoral Training Centre at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at King’s College London (KCL) has been launched to investigate symptom management for ...
High-grade gliomas are rare, malignant tumours which account for up to 12% of all childhood brain tumours Researchers in the US and UK are exploring a new type of cancer treatment as part of a £1.1m ...
The conference will take place on 23 to 24 October at Vienna AirportCity FlyPharma Vienna 2024’s agenda is now live on the conference website. As the global pharmaceutical landscape continues to ...
Areas include health research across life stages, from paediatrics to health ageing and resilience The University of Liverpool and McMaster University have announced an institutional strategic ...
The autoimmune disease, which affects 1.5 million people in the US, causes the body's immune system to attack its own tissues Researchers from Johns Hopkins Medicine have revealed that certain ...
Vicore Pharma and Endeavor BioMedicines have shared new data from two mid-stage clinical trials of two therapies that show promise in treating patients living with idiopathic pulmonary fibrosis (IPF).
Researchers from Imperial College London (ICL), the Alan Turing Institute and the Universities of Sheffield and Nottingham are aiming to develop and test the first-ever ‘digital twin’ heart models for ...
A new analysis led by the UK Health Security Agency (UKHSA) and Imperial College London (ICL) has confirmed that a variant called M1UK played a key role in the global increase of group A Streptococcus ...